Search hospitals > Massachusetts > Lowell
Lowell General Hospital
Claim this profileLowell, Massachusetts 01854
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Prostate Cancer
Conducts research for Non-Small Cell Lung Cancer
110 reported clinical trials
5 medical researchers
Summary
Lowell General Hospital is a medical facility located in Lowell, Massachusetts. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Prostate Cancer, Non-Small Cell Lung Cancer and other specialties. Lowell General Hospital is involved with conducting 110 clinical trials across 166 conditions. There are 5 research doctors associated with this hospital, such as Murat A. Anamur, Anasuya Gunturi, Sarah Paraghamian, and Matthew S. Katz.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 positive
PR positive
2Cancer
Global LeaderStage IV
Stage III
HER2 positive
Top PIs
Murat A. AnamurLowell General Hospital5 years of reported clinical research
Studies Cancer
Studies Lung Cancer
10 reported clinical trials
27 drugs studied
Anasuya GunturiLowell General Hospital3 years of reported clinical research
Studies Cancer
Studies Breast Cancer
8 reported clinical trials
20 drugs studied
Sarah ParaghamianTufts Medical Center3 years of reported clinical research
Studies Cancer
Studies Peritoneal Tumors
4 reported clinical trials
7 drugs studied
Matthew S. KatzLowell General Hospital4 years of reported clinical research
Studies Breast Cancer
Studies Coronavirus
3 reported clinical trials
7 drugs studied
Clinical Trials running at Lowell General Hospital
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Gallbladder Cancer
Bladder Cancer
Colorectal Cancer
Cancer
ALK Gene Rearrangement
Thyroid Cancer
Recurrence
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Lowell General Hospital?
Lowell General Hospital is a medical facility located in Lowell, Massachusetts. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Prostate Cancer, Non-Small Cell Lung Cancer and other specialties. Lowell General Hospital is involved with conducting 110 clinical trials across 166 conditions. There are 5 research doctors associated with this hospital, such as Murat A. Anamur, Anasuya Gunturi, Sarah Paraghamian, and Matthew S. Katz.